Sargent Bickham Lagudis’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $3.81M | Buy |
6,912
+122
| +2% | +$67.2K | 0.31% | 70 |
|
|
2022
Q3 | $3.44M | Buy |
6,790
+17
| +0.3% | +$8.62K | 0.31% | 67 |
|
|
2022
Q2 | $3.68M | Sell |
6,773
-372
| -5% | -$202K | 0.32% | 69 |
|
|
2022
Q1 | $4.22M | Buy |
7,145
+427
| +6% | +$252K | 0.33% | 66 |
|
|
2021
Q4 | $4.48M | Buy |
6,718
+311
| +5% | +$208K | 0.34% | 64 |
|
|
2021
Q3 | $3.66M | Buy |
6,407
+73
| +1% | +$41.7K | 0.3% | 73 |
|
|
2021
Q2 | $3.2M | Sell |
6,334
-197
| -3% | -$99.4K | 0.26% | 81 |
|
|
2021
Q1 | $2.98M | Buy |
6,531
+479
| +8% | +$219K | 0.26% | 78 |
|
|
2020
Q4 | $2.82M | Buy |
6,052
+320
| +6% | +$149K | 0.26% | 79 |
|
|
2020
Q3 | $2.53M | Sell |
5,732
-95
| -2% | -$41.9K | 0.25% | 78 |
|
|
2020
Q2 | $2.11M | Buy |
5,827
+1,211
| +26% | +$439K | 0.23% | 87 |
|
|
2020
Q1 | $1.31M | Buy |
4,616
+4,132
| +854% | +$1.17M | 0.17% | 100 |
|
|
2019
Q4 | $157K | Buy |
484
+29
| +6% | +$9.41K | 0.02% | 231 |
|
|
2019
Q3 | $133K | Sell |
455
-60
| -12% | -$17.5K | 0.02% | 225 |
|
|
2019
Q2 | $151K | Buy |
515
+60
| +13% | +$17.6K | 0.02% | 230 |
|
|
2019
Q1 | $125K | Hold |
455
| – | – | 0.01% | 257 |
|
|
2018
Q4 | $102K | Buy |
455
+130
| +40% | +$29.1K | 0.01% | 269 |
|
|
2018
Q3 | $79K | Hold |
325
| – | – | 0.01% | 306 |
|
|
2018
Q2 | $67K | Hold |
325
| – | – | 0.01% | 317 |
|
|
2018
Q1 | $67K | Sell |
325
-53
| -14% | -$10.9K | 0.01% | 315 |
|
|
2017
Q4 | $72K | Buy |
378
+53
| +16% | +$10.1K | 0.01% | 314 |
|
|
2017
Q3 | $61K | Hold |
325
| – | – | 0.01% | 343 |
|
|
2017
Q2 | $57K | Buy |
325
+25
| +8% | +$4.39K | 0.01% | 342 |
|
|
2017
Q1 | $46K | Hold |
300
| – | – | 0.01% | 374 |
|
|
2016
Q4 | $42K | Sell |
300
-150
| -33% | -$21K | 0.01% | 367 |
|
|
2016
Q3 | $72 | Buy |
450
+10
| +2% | +$2 | 0.01% | 293 |
|
|
2016
Q2 | $65K | Buy |
440
+40
| +10% | +$5.91K | 0.01% | 310 |
|
|
2016
Q1 | $57K | Buy |
+400
| New | +$57K | 0.01% | 344 |
|